Additionally, the ferroptosis inducers sorafenib and erastin promote cuproptosis in primary hepatocellular carcinoma by inhibiting FDX1 protein degradation via inhibition of cystine transport and by decreasing synthesis of the intracellular copper chelator GSH (Wang et al., 2023). The gene discussed is FDX1; the disease is hepatocellular carcinoma.